 |
Prescription and Over-the-Counter Drug Product List - 22nd Edition
Cumulative Supplement Number 10: October 2002
NOTE: The format for the Monthly Additions/Deletions Drug Product List has changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section CUMULATIVE SUPPLEMENT LEGEND.
ACETAMINOPHEN; HYDROCODONE BITARTRATE
TABLET; ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
>A> AA ABLE 325MG;7.5MG N40464 001 OCT 23, 2002 OCT NEWA
>A> AA 325MG;10MG N40464 002 OCT 23, 2002 OCT NEWA
>A> AA 650MG;10MG N40476 001 OCT 23, 2002 OCT NEWA
>A> AA 750MG;7.5MG N40469 001 OCT 25, 2002 OCT NEWA
>A> AA MALLINCKRODT 750MG;10MG N40468 001 OCT 31, 2002 OCT NEWA
>D> + WATSON LABS 750MG;10MG N40094 004 MAR 22, 1999 OCT CFTG
>A> AA + 750MG;10MG N40094 004 MAR 22, 1999 OCT CFTG
AMIODARONE HYDROCHLORIDE
INJECTABLE; INJECTION
>A> AMIODARONE HCL
>A> AP ABBOTT 50MG/ML N75955 001 OCT 18, 2002 OCT NEWA
>A> AP AM PHARM PARTNERS 50MG/ML N75761 001 OCT 15, 2002 OCT NEWA
>A> AP BEDFORD 50MG/ML N76018 001 OCT 15, 2002 OCT NEWA
>A> AP BEDFORD LABS 50MG/ML N76299 001 OCT 24, 2002 OCT NEWA
>A> AP BEN VENUE 50MG/ML N76088 001 OCT 15, 2002 OCT NEWA
>A> AP FAULDING 50MG/ML N76108 001 OCT 15, 2002 OCT NEWA
>A> AP PHARMAFORCE 50MG/ML N76217 001 OCT 15, 2002 OCT NEWA
CORDARONE
>D> + WYETH AYERST 50MG/ML N20377 001 AUG 03, 1995 OCT CFTG
>A> AP + 50MG/ML N20377 001 AUG 03, 1995 OCT CFTG
TABLET; ORAL
AMIODARONE HCL
>D> + EON 400MG N75315 002 JUN 30, 2000 OCT CRLD
>A> + 400MG N75315 002 JUN 30, 2000 OCT CRLD
CORDARONE
>D> AB + WYETH AYERST 200MG N18972 001 DEC 24, 1985 OCT CRLD
>A> AB 200MG N18972 001 DEC 24, 1985 OCT CRLD
AMOXICILLIN; CLAVULANATE POTASSIUM
TABLET; ORAL
AMOXICILLIN AND CLAVULANATE POTASSIUM
>A> AB TEVA 500MG;EQ 125MG BASE N65101 001 OCT 30, 2002 OCT NEWA
>A> AB 875MG;EQ 125MG BASE N65096 001 OCT 29, 2002 OCT NEWA
BECLOMETHASONE DIPROPIONATE MONOHYDRATE
SPRAY, METERED; NASAL
VANCENASE AQ
>D> + SCHERING EQ 0.084MG DIPROP/SPRAY N20469 001 JUN 26, 1996 OCT DISC
>A> @ EQ 0.084MG DIPROP/SPRAY N20469 001 JUN 26, 1996 OCT DISC
BISOPROLOL FUMARATE
TABLET; ORAL
BISOPROLOL FUMARATE
>A> AB MUTUAL PHARM 5MG N75474 001 OCT 25, 2002 OCT NEWA
>A> AB 10MG N75474 002 OCT 25, 2002 OCT NEWA
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
SYRUP; ORAL
>D> BROMANATE DM
>D> AA ALPHARMA 2MG/5ML;10MG/5ML;30MG/5ML N88722 001 MAR 07, 1985 OCT DISC
>A> @ 2MG/5ML;10MG/5ML;30MG/5ML N88722 001 MAR 07, 1985 OCT DISC
BUPRENORPHINE HYDROCHLORIDE
>A> TABLET; SUBLINGUAL
>A> SUBUTEX
>A> RECKITT BENCKISER EQ 2MG BASE N20732 002 OCT 08, 2002 OCT NEWA
>A> + EQ 8MG BASE N20732 003 OCT 08, 2002 OCT NEWA
>A> BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
>A> TABLET; SUBLINGUAL
>A> SUBOXONE
>A> RECKITT BENCKISER 2MG;0.5MG N20733 001 OCT 08, 2002 OCT NEWA
>A> + 8MG;2MG N20733 002 OCT 08, 2002 OCT NEWA
BUTABARBITAL SODIUM
TABLET; ORAL
BUTISOL SODIUM
>D> + WALLACE LABS 15MG N00793 002 OCT DISC
>A> @ 15MG N00793 002 OCT DISC
>D> + 100MG N00793 005 OCT DISC
>A> @ 100MG N00793 005 OCT DISC
BUTENAFINE HYDROCHLORIDE
CREAM; TOPICAL
>A> MENTAX-TC
>A> + BERTEK 1% N21408 001 OCT 17, 2002 OCT NEWA
CEFUROXIME AXETIL
TABLET; ORAL
CEFUROXIME AXETIL
>A> AB APOTEX EQ 250MG BASE N65069 001 OCT 02, 2002 OCT NEWA
>A> AB EQ 500MG BASE N65069 002 OCT 02, 2002 OCT NEWA
CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE
>D> TABLET; ORAL
>D> CLONIDINE HCL AND CHLORTHALIDONE
>D> AB PAR PHARM 15MG;0.3MG N71142 001 DEC 16, 1987 OCT DISC
>A> @ 15MG;0.3MG N71142 001 DEC 16, 1987 OCT DISC
>D> AB 15MG;0.2MG N71178 001 DEC 16, 1987 OCT DISC
>A> @ 15MG;0.2MG N71178 001 DEC 16, 1987 OCT DISC
>D> AB 15MG;0.1MG N71179 001 DEC 16, 1987 OCT DISC
>A> @ 15MG;0.1MG N71179 001 DEC 16, 1987 OCT DISC
CLORPRES
>D> AB MYLAN 15MG;0.3MG N71325 001 FEB 09, 1987 OCT CRLD
>A> + 15MG;0.3MG N71325 001 FEB 09, 1987 OCT CRLD
>D> COMBIPRES
>D> AB BOEHRINGER INGELHEIM 15MG;0.1MG N17503 001 OCT DISC
>D> AB 15MG;0.2MG N17503 002 OCT DISC
>D> AB + 15MG;0.3MG N17503 003 APR 10, 1984 OCT DISC
>A> @ 15MG;0.1MG N17503 001 OCT DISC
>A> @ 15MG;0.3MG N17503 003 APR 10, 1984 OCT DISC
>A> @ 15MG;0.2MG N17503 002 OCT DISC
CLINDAMYCIN PHOSPHATE
GEL; TOPICAL
CLINDAGEL
>D> BT GALDERMA LABS LP EQ 1% BASE N50782 001 NOV 27, 2000 OCT CTNA
>A> BT EQ 1% BASE N50782 001 NOV 27, 2000 OCT CTNA
DACARBAZINE
INJECTABLE; INJECTION
DACARBAZINE
>D> AP GENSIA SICOR PHARMS 500MG/VIAL N75259 001 SEP 22, 2000 OCT CRLD
>A> AP + 500MG/VIAL N75259 001 SEP 22, 2000 OCT CRLD
DEXAMETHASONE SODIUM PHOSPHATE
INJECTABLE; INJECTION
>D> DECADRON
>D> AP + MERCK EQ 4MG PHOSPHATE/ML N12071 002 OCT DISC
>A> @ EQ 4MG PHOSPHATE/ML N12071 002 OCT DISC
>D> + EQ 24MG PHOSPHATE/ML N12071 004 OCT DISC
>A> @ EQ 24MG PHOSPHATE/ML N12071 004 OCT DISC
DEXAMETHASONE
>D> AP AM PHARM PARTNERS EQ 10MG PHOSPHATE/ML N88469 001 JAN 25, 1984 OCT DISC
>A> @ EQ 10MG PHOSPHATE/ML N88469 001 JAN 25, 1984 OCT DISC
DEXAMETHASONE SODIUM PHOSPHATE
>D> AP GENSIA SICOR PHARMS EQ 10MG PHOSPHATE/ML N81126 001 AUG 31, 1990 OCT CRLD
>A> AP + EQ 10MG PHOSPHATE/ML N81126 001 AUG 31, 1990 OCT CRLD
>D> AP LUITPOLD EQ 4MG PHOSPHATE/ML N87440 001 JUL 21, 1982 OCT CRLD
>A> AP + EQ 4MG PHOSPHATE/ML N87440 001 JUL 21, 1982 OCT CRLD
>D> AP STERIS EQ 4MG PHOSPHATE/ML N89169 001 APR 09, 1986 OCT DISC
>A> @ EQ 4MG PHOSPHATE/ML N89169 001 APR 09, 1986 OCT DISC
>D> AP EQ 10MG PHOSPHATE/ML N87668 001 JUL 01, 1982 OCT DISC
>A> @ EQ 10MG PHOSPHATE/ML N87668 001 JUL 01, 1982 OCT DISC
>D> HEXADROL
>D> AP + ORGANON EQ 4MG PHOSPHATE/ML N14694 002 OCT DISC
>A> @ EQ 4MG PHOSPHATE/ML N14694 002 OCT DISC
>D> AP + EQ 10MG PHOSPHATE/ML N14694 003 OCT DISC
>A> @ EQ 10MG PHOSPHATE/ML N14694 003 OCT DISC
DEXTROAMPHETAMINE SULFATE
TABLET; ORAL
DEXTROAMPHETAMINE SULFATE
>A> AA KV PHARM 5MG N40365 001 OCT 31, 2002 OCT NEWA
>A> AA 10MG N40367 001 OCT 31, 2002 OCT NEWA
DIAZEPAM
INJECTABLE; INJECTION
DIAZEPAM
>D> AP ABBOTT 5MG/ML N71583 001 OCT 13, 1987 OCT CRLD
>A> AP + 5MG/ML N71583 001 OCT 13, 1987 OCT CRLD
>D> AP + ROCHE 5MG/ML N16087 001 OCT DISC
>A> @ 5MG/ML N16087 001 OCT DISC
DUTASTERIDE
CAPSULE; ORAL
AVODART
>D> + GLAXOSMITHKLINE 0.5MG N21319 001 NOV 20, 2001 OCT CTNA
>A> + 0.5MG N21319 001 NOV 20, 2001 OCT CTNA
ETHOSUXIMIDE
CAPSULE; ORAL
>A> ETHOSUXIMIDE
>A> AB BANNER PHARMACAPS 250MG N40430 001 OCT 28, 2002 OCT NEWA
ZARONTIN
>D> + PARKE DAVIS 250MG N12380 001 OCT CFTG
>A> AB + 250MG N12380 001 OCT CFTG
>A> EZETIMIBE
>A> TABLET; ORAL
>A> ZETIA
>A> + MSP SINGAPORE 10MG N21445 001 OCT 25, 2002 OCT NEWA
FLECAINIDE ACETATE
TABLET; ORAL
FLECAINIDE ACETATE
>A> AB BARR 50MG N75882 001 OCT 28, 2002 OCT NEWA
>A> AB 100MG N75882 002 OCT 28, 2002 OCT NEWA
>A> AB 150MG N75882 003 OCT 28, 2002 OCT NEWA
>A> AB GENEVA PHARMS TECH 50MG N76030 001 OCT 28, 2002 OCT NEWA
>A> AB 100MG N76030 002 OCT 28, 2002 OCT NEWA
>A> AB 150MG N76030 003 OCT 28, 2002 OCT NEWA
>A> GLIPIZIDE; METFORMIN HYDROCHLORIDE
>A> TABLET; ORAL
>A> METAGLIP
>A> BRISTOL MYERS SQUIBB 2.5MG;250MG N21460 001 OCT 21, 2002 OCT NEWA
>A> 2.5MG;500MG N21460 002 OCT 21, 2002 OCT NEWA
>A> + 5MG;500MG N21460 003 OCT 21, 2002 OCT NEWA
HYDROCORTISONE
TABLET; ORAL
CORTEF
>D> + PHARMACIA AND UPJOHN 5MG N08697 003 OCT CRLD
>A> 5MG N08697 003 OCT CRLD
>D> BP + 10MG N08697 001 OCT CRLD
>A> BP 10MG N08697 001 OCT CRLD
HYDROCORTISONE ACETATE
>D> INJECTABLE; INJECTION
>D> HYDROCORTISONE ACETATE
>D> + STERIS 25MG/ML N83128 001 OCT DISC
>A> @ 25MG/ML N83128 001 OCT DISC
KETAMINE HYDROCHLORIDE
INJECTABLE; INJECTION
KETAMINE HCL
>A> AP BIONICHE (CANADA) EQ 100MG BASE/ML N76092 003 OCT 25, 2002 OCT NEWA
LEVOTHYROXINE SODIUM
TABLET; ORAL
THYRO-TABS
>A> BX LLOYD 0.025MG N21116 001 OCT 24, 2002 OCT NEWA
>A> BX 0.05MG N21116 002 OCT 24, 2002 OCT NEWA
>A> BX 0.075MG N21116 003 OCT 24, 2002 OCT NEWA
>A> BX 0.088MG N21116 010 OCT 24, 2002 OCT NEWA
>A> BX 0.1MG N21116 004 OCT 24, 2002 OCT NEWA
>A> BX 0.112MG N21116 011 OCT 24, 2002 OCT NEWA
>A> BX 0.125MG N21116 005 OCT 24, 2002 OCT NEWA
>A> BX 0.15MG N21116 006 OCT 24, 2002 OCT NEWA
>A> BX 0.175MG N21116 007 OCT 24, 2002 OCT NEWA
>A> BX 0.2MG N21116 008 OCT 24, 2002 OCT NEWA
>A> BX + 0.3MG N21116 009 OCT 24, 2002 OCT NEWA
>A> METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE
>A> TABLET; ORAL
>A> AVANDAMET
>A> GLAXOSMITHKLINE 500MG;EQ 1MG BASE N21410 001 OCT 10, 2002 OCT NEWA
>A> 500MG;EQ 2MG BASE N21410 002 OCT 10, 2002 OCT NEWA
>A> + 500MG;EQ 4MG BASE N21410 003 OCT 10, 2002 OCT NEWA
METHYCLOTHIAZIDE; RESERPINE
>D> TABLET; ORAL
>D> DIUTENSEN-R
>D> + WALLACE LABS 2.5MG;0.1MG N12708 005 OCT DISC
>A> @ 2.5MG;0.1MG N12708 005 OCT DISC
MIDAZOLAM HYDROCHLORIDE
INJECTABLE; INJECTION
MIDAZOLAM HCL
>D> AP ABBOTT EQ 1MG BASE/ML N75293 001 JUN 20, 2000 OCT CRLD
>A> AP + EQ 1MG BASE/ML N75293 001 JUN 20, 2000 OCT CRLD
>D> AP EQ 5MG BASE/ML N75293 002 JUN 20, 2000 OCT CRLD
>A> AP + EQ 5MG BASE/ML N75293 002 JUN 20, 2000 OCT CRLD
>D> VERSED
>D> AP + HLR EQ 1MG BASE/ML N18654 002 MAY 26, 1987 OCT DISC
>A> @ EQ 1MG BASE/ML N18654 002 MAY 26, 1987 OCT DISC
>D> AP + EQ 5MG BASE/ML N18654 001 DEC 20, 1985 OCT DISC
>A> @ EQ 5MG BASE/ML N18654 001 DEC 20, 1985 OCT DISC
MIDODRINE HYDROCHLORIDE
TABLET; ORAL
PROAMATINE
>D> SHIRE LABS 10MG N19815 003 MAR 20, 2002 OCT CRLD
>D> SHIRE PHARM 5MG N19815 002 SEP 06, 1996 OCT CRLD
>A> + 5MG N19815 002 SEP 06, 1996 OCT CRLD
>A> 10MG N19815 003 MAR 20, 2002 OCT CRLD
MIFEPRISTONE
TABLET; ORAL
MIFEPREX
>A> + DANCO LABS LLC 200MG N20687 001 SEP 28, 2000 OCT CAHN
>D> + POPULATION COUNCIL 200MG N20687 001 SEP 28, 2000 OCT CAHN
MORPHINE SULFATE
TABLET, EXTENDED RELEASE; ORAL
MS CONTIN
>D> AB + PURDUE FREDERICK 15MG N19516 003 SEP 12, 1989 OCT CRLD
>A> AB 15MG N19516 003 SEP 12, 1989 OCT CRLD
>D> AB + 30MG N19516 001 MAY 29, 1987 OCT CRLD
>A> AB 30MG N19516 001 MAY 29, 1987 OCT CRLD
>D> AB + 100MG N19516 004 JAN 16, 1990 OCT CRLD
>A> AB 100MG N19516 004 JAN 16, 1990 OCT CRLD
>D> AB + 200MG N19516 005 NOV 08, 1993 OCT CRLD
>A> AB 200MG N19516 005 NOV 08, 1993 OCT CRLD
NORETHINDRONE
TABLET; ORAL-28
>A> CAMILA
>A> AB1 BARR 0.35MG N76177 001 OCT 21, 2002 OCT NEWA
>A> ERRIN
>A> AB2 BARR 0.35MG N76225 001 OCT 21, 2002 OCT NEWA
MICRONOR
>D> + ORTHO MCNEIL PHARM 0.35MG N16954 001 JAN 02, 2073 OCT CFTG
>A> AB2 + 0.35MG N16954 001 JAN 02, 2073 OCT CFTG
NOR-QD
>D> + WATSON LABS (UTAH) 0.35MG N17060 001 JAN 02, 2073 OCT CFTG
>A> AB1 + 0.35MG N17060 001 JAN 02, 2073 OCT CFTG
OLANZAPINE
TABLET; ORAL
ZYPREXA
>D> + LILLY 2.5MG N20592 001 SEP 30, 1996 OCT CRLD
>A> 2.5MG N20592 001 SEP 30, 1996 OCT CRLD
>A> OXAPROZIN POTASSIUM
>A> TABLET; ORAL
>A> DAYRO ALTA
>A> + AHARMACIA 600MG N20776 001 OCT 17, 2002 OCT NEWA
PAROXETINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
PAXIL CR
>D> + GLAXOSMITHKLINE EQ 12.5MG BASE N20936 001 FEB 16, 1999 OCT CRLD
>A> EQ 12.5MG BASE N20936 001 FEB 16, 1999 OCT CRLD
>D> + EQ 25MG BASE N20936 002 FEB 16, 1999 OCT CRLD
>A> EQ 25MG BASE N20936 002 FEB 16, 1999 OCT CRLD
PROPAFENONE HYDROCHLORIDE
TABLET; ORAL
PROPAFENONE HCL
>A> AB VINTAGE PHARMS 150MG N75938 001 OCT 17, 2002 OCT NEWA
>A> AB 225MG N75938 002 OCT 17, 2002 OCT NEWA
>A> AB 300MG N75938 003 OCT 17, 2002 OCT NEWA
TAZAROTENE
CREAM; TOPICAL
>A> AVAGE
>A> + ALLERGAN 0.1% N21184 003 SEP 30, 2002 OCT NEWA
TESTOSTERONE
GEL; TOPICAL
>A> TESTIM
>A> + AUXILIUM A2 1% N21454 001 OCT 31, 2002 OCT NEWA
THEOPHYLLINE
TABLET, EXTENDED RELEASE; ORAL
THEO-DUR
>D> AB + KEY PHARMS 100MG N85328 001 OCT CRLD
>D> AB + 200MG N86998 001 OCT CRLD
>D> AB + 300MG N85328 002 OCT CRLD
>D> AB + 450MG N89131 001 JUN 25, 1986 OCT CRLD
>A> AB SCHERING 100MG N85328 001 OCT CRLD
>A> AB 200MG N86998 001 OCT CRLD
>A> AB 300MG N85328 002 OCT CRLD
>A> AB 450MG N89131 001 JUN 25, 1986 OCT CRLD
THEOPHYLLINE
>D> AB SIDMAK LABS NJ 100MG N89807 001 APR 30, 1990 OCT CRLD
>A> AB + 100MG N89807 001 APR 30, 1990 OCT CRLD
>D> AB 200MG N89808 001 APR 30, 1990 OCT CRLD
>A> AB + 200MG N89808 001 APR 30, 1990 OCT CRLD
>D> AB 300MG N89763 001 APR 30, 1990 OCT CRLD
>A> AB + 300MG N89763 001 APR 30, 1990 OCT CRLD
>D> AB 450MG N81236 001 NOV 09, 1992 OCT CRLD
>A> AB + 450MG N81236 001 NOV 09, 1992 OCT CRLD
UNI-DUR
>D> BC + SCHERING 400MG N89822 001 JAN 04, 1995 OCT CRLD
>A> BC 400MG N89822 001 JAN 04, 1995 OCT CRLD
>D> BC + 600MG N89823 001 JAN 04, 1995 OCT CRLD
>A> BC 600MG N89823 001 JAN 04, 1995 OCT CRLD
UNIPHYL
>D> BC PURDUE FREDERICK 400MG N87571 001 SEP 01, 1982 OCT CRLD
>A> BC + 400MG N87571 001 SEP 01, 1982 OCT CRLD
>D> BC 600MG N40086 001 APR 15, 1996 OCT CRLD
>A> BC + 600MG N40086 001 APR 15, 1996 OCT CRLD
TIZANIDINE HYDROCHLORIDE
TABLET; ORAL
TIZANIDINE HCL
>A> AB COREPHARMA EQ 2MG BASE N76347 001 OCT 11, 2002 OCT NEWA
>A> AB EQ 4MG BASE N76347 002 OCT 11, 2002 OCT NEWA
TRIAMCINOLONE DIACETATE
INJECTABLE; INJECTION
ARISTOCORT
>A> + FUJISAWA HLTHCARE 25MG/ML N11685 003 OCT CAHN
>A> + 40MG/ML N12802 001 OCT CAHN
>D> + LEDERLE 25MG/ML N11685 003 OCT CAHN
>D> + 40MG/ML N12802 001 OCT CAHN
TRIAMCINOLONE HEXACETONIDE
INJECTABLE; INJECTION
ARISTOSPAN
>A> + FUJISAWA HLTHCARE 5MG/ML N16466 001 OCT CAHN
>A> + 20MG/ML N16466 002 OCT CAHN
>D> + LEDERLE 5MG/ML N16466 001 OCT CAHN
>D> + 20MG/ML N16466 002 OCT CAHN
CHLORHEXIDINE GLUCONATE
>A> SOLUTION; TOPICAL
>A> CHLORAPREP ONE-STEP SEPP
>A> + BECKLOFF 2% N21555 001 OCT 07, 2002 OCT NEWA
FAMOTIDINE
TABLET; ORAL
FAMOTIDINE
>A> EON 10MG N76101 001 OCT 21, 2002 OCT NEWA
IBUPROFEN
CAPSULE; ORAL
IBUPROFEN
>A> BANNER PHARMACAPS 200MG N21472 001 OCT 18, 2002 OCT NEWA
NICOTINE POLACRILEX
>A> TROCHE/LOZENGE; ORAL
>A> COMMIT
>A> GLAXOSMITHKLINE CONS 2MG N21330 001 OCT 31, 2002 OCT NEWA
>A> + 4MG N21330 002 OCT 31, 2002 OCT NEWA
Last update: July 15, 2005 |
|
